An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.

This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices and Implantable Infusion Pumps, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices and Implantable Infusion Pumps.

Report Scope

The Neuromodulation Devices and Implantable Infusion Pumps market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuromodulation Devices and Implantable Infusion Pumps market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuromodulation Devices and Implantable Infusion Pumps manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuromodulation Devices and Implantable Infusion Pumps Market Report

Report Metric	Details
Report Name	Neuromodulation Devices and Implantable Infusion Pumps Market
Segment by Type	Spinal Cord Stimulation Deep Brain Stimulation Sacral Nerve Stimulation Vagal Nerve Stimulation Gastric Stimulation Transcranial Magnetic Stimulation Transcutaneous Electrical Stimulation Other
Segment by Application	Parkinson's Disease Epilepsy Pain Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuromodulation Devices and Implantable Infusion Pumps in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

What is the market share of major companies in Neuromodulation Devices and Implantable Infusion Pumps Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Neuromodulation Devices and Implantable Infusion Pumps Market share by type?

Ans: In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%.

Who are the main players in the Neuromodulation Devices and Implantable Infusion Pumps Market report?

Ans: The main players in the Neuromodulation Devices and Implantable Infusion Pumps Market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical

What are the Application segmentation covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report?

Ans: The Applications covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report are Parkinson's Disease, Epilepsy, Pain, Other

What are the Type segmentation covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report?

Ans: The Types covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report are Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Transcranial Magnetic Stimulation, Transcutaneous Electrical Stimulation, Other

1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview

1.1 Product Overview and Scope of Neuromodulation Devices and Implantable Infusion Pumps

1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type

1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Value Comparison by Type (2024-2030)

1.2.2 Spinal Cord Stimulation

1.2.3 Deep Brain Stimulation

1.2.4 Sacral Nerve Stimulation

1.2.5 Vagal Nerve Stimulation

1.2.6 Gastric Stimulation

1.2.7 Transcranial Magnetic Stimulation

1.2.8 Transcutaneous Electrical Stimulation

1.2.9 Other

1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application

1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Application: (2024-2030)

1.3.2 Parkinson's Disease

1.3.3 Epilepsy

1.3.4 Pain

1.3.5 Other

1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts

1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2030

1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2030

1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Neuromodulation Devices and Implantable Infusion Pumps Market Competition by Manufacturers

2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2019-2024)

2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2019-2024)

2.4 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Type & Application

2.7 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends

2.7.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue

2.7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region

3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2019-2030

3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2019-2024

3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2025-2030

3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2019-2030

3.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2019-2024

3.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2025-2030

3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country

3.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)

3.4.3 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country

3.5.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)

3.5.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country

3.6.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)

3.6.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country

3.7.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)

3.7.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country

3.8.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)

3.8.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2030)

4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024)

4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2025-2030)

4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2030)

4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2030)

4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2024)

4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2025-2030)

4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2030)

4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2019-2030)

5 Segment by Application

5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2030)

5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024)

5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2025-2030)

5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2030)

5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2030)

5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2024)

5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2025-2030)

5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2019-2030)

5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Corporation Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific Corporation

6.2.1 Boston Scientific Corporation Corporation Information

6.2.2 Boston Scientific Corporation Description and Business Overview

6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.2.5 Boston Scientific Corporation Recent Developments/Updates

6.3 St. Jude Medical

6.3.1 St. Jude Medical Corporation Information

6.3.2 St. Jude Medical Description and Business Overview

6.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.3.5 St. Jude Medical Recent Developments/Updates

6.4 Synapse Biomedical

6.4.1 Synapse Biomedical Corporation Information

6.4.2 Synapse Biomedical Description and Business Overview

6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.4.5 Synapse Biomedical Recent Developments/Updates

6.5 Nevro Corporation

6.5.1 Nevro Corporation Corporation Information

6.5.2 Nevro Corporation Description and Business Overview

6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.5.5 Nevro Corporation Recent Developments/Updates

6.6 Neuropace

6.6.1 Neuropace Corporation Information

6.6.2 Neuropace Description and Business Overview

6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.6.5 Neuropace Recent Developments/Updates

6.7 Cyberonics

6.6.1 Cyberonics Corporation Information

6.6.2 Cyberonics Description and Business Overview

6.6.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.7.5 Cyberonics Recent Developments/Updates

6.8 Autonomic Technologies

6.8.1 Autonomic Technologies Corporation Information

6.8.2 Autonomic Technologies Description and Business Overview

6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.8.5 Autonomic Technologies Recent Developments/Updates

6.9 Avery Biomedical

6.9.1 Avery Biomedical Corporation Information

6.9.2 Avery Biomedical Description and Business Overview

6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.9.5 Avery Biomedical Recent Developments/Updates

6.10 Greatbatch Medical

6.10.1 Greatbatch Medical Corporation Information

6.10.2 Greatbatch Medical Description and Business Overview

6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio

6.10.5 Greatbatch Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain Analysis

7.2 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process

7.4 Neuromodulation Devices and Implantable Infusion Pumps Sales and Marketing

7.4.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels

7.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors

7.5 Neuromodulation Devices and Implantable Infusion Pumps Customers

8 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics

8.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends

8.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers

8.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges

8.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Boston Scientific Corporation

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

List of Tables

Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation by Manufacturers in 2023

Table 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) of Key Manufacturers (2019-2024)

Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Neuromodulation Devices and Implantable Infusion Pumps, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Type & Application

Table 12. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019-2024) & (Unit)

Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2019-2024)

Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2025-2030) & (Unit)

Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2025-2030)

Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2019-2024)

Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2025-2030)

Table 25. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)

Table 27. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2025-2030) & (Unit)

Table 28. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)

Table 32. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2025-2030) & (Unit)

Table 33. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019-2024) & (Unit)

Table 37. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2025-2030) & (Unit)

Table 38. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)

Table 42. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2025-2030) & (Unit)

Table 43. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)

Table 47. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2025-2030) & (Unit)

Table 48. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Type (2019-2024)

Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Type (2025-2030)

Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)

Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2025-2030)

Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2024)

Table 57. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2025-2030)

Table 58. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2019-2024)

Table 59. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2025-2030)

Table 60. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Application (2019-2024)

Table 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Application (2025-2030)

Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)

Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2025-2030)

Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2019-2024)

Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2025-2030)

Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2019-2024)

Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2025-2030)

Table 70. Medtronic Corporation Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Boston Scientific Corporation Corporation Information

Table 76. Boston Scientific Corporation Description and Business Overview

Table 77. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product

Table 79. Boston Scientific Corporation Recent Developments/Updates

Table 80. St. Jude Medical Corporation Information

Table 81. St. Jude Medical Description and Business Overview

Table 82. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 84. St. Jude Medical Recent Developments/Updates

Table 85. Synapse Biomedical Corporation Information

Table 86. Synapse Biomedical Description and Business Overview

Table 87. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 89. Synapse Biomedical Recent Developments/Updates

Table 90. Nevro Corporation Corporation Information

Table 91. Nevro Corporation Description and Business Overview

Table 92. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product

Table 94. Nevro Corporation Recent Developments/Updates

Table 95. Neuropace Corporation Information

Table 96. Neuropace Description and Business Overview

Table 97. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product

Table 99. Neuropace Recent Developments/Updates

Table 100. Cyberonics Corporation Information

Table 101. Cyberonics Description and Business Overview

Table 102. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product

Table 104. Cyberonics Recent Developments/Updates

Table 105. Autonomic Technologies Corporation Information

Table 106. Autonomic Technologies Description and Business Overview

Table 107. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product

Table 109. Autonomic Technologies Recent Developments/Updates

Table 110. Avery Biomedical Corporation Information

Table 111. Avery Biomedical Description and Business Overview

Table 112. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 114. Avery Biomedical Recent Developments/Updates

Table 115. Greatbatch Medical Corporation Information

Table 116. Greatbatch Medical Description and Business Overview

Table 117. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 119. Greatbatch Medical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Neuromodulation Devices and Implantable Infusion Pumps Distributors List

Table 123. Neuromodulation Devices and Implantable Infusion Pumps Customers List

Table 124. Neuromodulation Devices and Implantable Infusion Pumps Market Trends

Table 125. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers

Table 126. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges

Table 127. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Neuromodulation Devices and Implantable Infusion Pumps

Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Type in 2023 & 2030

Figure 4. Spinal Cord Stimulation Product Picture

Figure 5. Deep Brain Stimulation Product Picture

Figure 6. Sacral Nerve Stimulation Product Picture

Figure 7. Vagal Nerve Stimulation Product Picture

Figure 8. Gastric Stimulation Product Picture

Figure 9. Transcranial Magnetic Stimulation Product Picture

Figure 10. Transcutaneous Electrical Stimulation Product Picture

Figure 11. Other Product Picture

Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application in 2023 & 2030

Figure 14. Parkinson's Disease

Figure 15. Epilepsy

Figure 16. Pain

Figure 17. Other

Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (2019-2030) & (US$ Million)

Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2019-2030) & (Unit)

Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) & (2019-2030)

Figure 22. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered

Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers in 2023

Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers in 2023

Figure 25. The Global 5 and 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players: Market Share by Revenue in 2023

Figure 26. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 28. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2030)

Figure 29. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2030)

Figure 30. U.S. Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2030)

Figure 33. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2030)

Figure 34. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. U.K. Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2019-2030)

Figure 40. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2019-2030)

Figure 41. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Indonesia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Thailand Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Malaysia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2030)

Figure 51. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2030)

Figure 52. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Argentina Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2030)

Figure 56. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2030)

Figure 57. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. UAE Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. Global Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2019-2030)

Figure 61. Global Revenue Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2019-2030)

Figure 62. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2019-2030)

Figure 63. Global Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Application (2019-2030)

Figure 64. Global Revenue Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Application (2019-2030)

Figure 65. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2019-2030)

Figure 66. Neuromodulation Devices and Implantable Infusion Pumps Value Chain

Figure 67. Neuromodulation Devices and Implantable Infusion Pumps Production Process

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Distributors Profiles

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions